Immune monitoring in COVID-19 patients
Currently it is not clear which patients who are admitted to the hospital with a SARS‐CoV‐2 infection will benefit from treatment or die. Clearly, the balanced immune system is lost in some of the SARS‐CoV‐2 infected patients which contributes to the progression in disease.
We believe that monitoring the immunological changes induced by the SARS‐CoV‐2 virus will lead to discovering prognostic or predictive markers that may assist in decision making and offers therapeutic options.
More detailed information
Prof. dr. C.H.J. van Eijck
Role Erasmus MC: